dr. farago on combination of olaparib and temozolomide in small cell lung cancer
Published 6 years ago • 157 plays • Length 1:45Download video MP4
Download video MP3
Similar videos
-
4:05
olaparib and temozolomide for relapsed small cell lung cancer
-
2:49
a study exploring olaparib and temozolomide in small cell lung cancer
-
2:50
dr. farago on effectiveness of single-agent lurbinectedin in sclc
-
1:09
dr. farago on opportunities to investigate biomarkers for small cell lung cancer
-
1:41
dr. farago on eligibility criteria for frontline immunotherapy in sclc
-
2:30
co-clinical trial of olaparib and temozolomide in sclc pdx models
-
0:35
dr. farago on the fda approval of pembrolizumab for lower pd-1 cutoff nsclc
-
1:02
dr. forster discusses the atlantis study in small-cell lung cancer
-
1:44
dr. liu on the checkmate-032 trial in sclc
-
3:13
dr. herzog on the fda approval of olaparib/bevacizumab as frontline maintenance in ovarian cancer
-
2:07
maintenance olaparib in patients with ovarian cancer
-
4:47
immune checkpoint inhibitors in small-cell lung cancer
-
0:56
dr. levine on combos with parp inhibitors in ovarian cancer
-
1:27
dr. chiang discusses ipilimumab plus nivolumab in small cell lung cancer
-
2:10
dr. gulley discusses a phase ii study of olaparib and durvalumab in mcrpc
-
6:51
platinum sensitivity and parp inhibition in ovarian cancer
-
2:46
dr. brufsky on the fda approval of olaparib in brca breast cancer
-
1:23
dr. robertson on olaparib for serous ovarian cancer
-
2:21
dr. rafii discusses clinical outcomes with olaparib in patients with ovarian cancer